"This debt financing extends our cash runway well into late 2014 at a critical time in our clinical product development cycle.
http://www.biospace.com/news_story.aspx?StoryID=291421&full=1
http://www.biospace.com/news_story.aspx?StoryID=291421&full=1
No comments:
Post a Comment